122
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

The Association of Medicaid expansion with prescription drug utilization and expenditure among low-income participants with asthma

, PhD, MPHORCID Icon, , MD, PhD, , PhD, MBA & , RPh, MSc
Pages 2030-2039 | Received 20 Sep 2022, Accepted 08 May 2023, Published online: 31 May 2023

References

  • Centers for Disease Control and Prevention. Most Recent National Asthma Data 2020 [Available from: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.
  • National AE, Prevention P. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94.
  • Baxi SN, Phipatanakul W. The role of allergen exposure and avoidance in asthma. Adolesc Med. 2010;21(1):57.
  • Vasileiou E, Sheikh A, Butler C, El Ferkh K, von Wissmann B, McMenamin J, Ritchie L, Schwarze J, Papadopoulos NG, Johnston SL, et al. Effectiveness of influenza vaccines in asthma: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(8):1388–1395. doi:10.1093/cid/cix524.
  • Global Initiative for Asthma (GINA). Pocket guide for asthma management and prevention 2020 2020 [Available from: https://ginasthma.org/wp-content/uploads/2020/04/Main-pocket-guide_2020_04_03-final-wms.pdf.
  • American Academy of Allergy Asthma & Immunology A. AAAAI ALLERGY AND ASTHMA DRUG GUIDE 2019.
  • Perry R, Braileanu G, Palmer T, Stevens P. The economic burden of pediatric asthma in the United States: literature review of current evidence. Pharmacoeconomics. 2019;37(2):155–167. doi:10.1007/s40273-018-0726-2.
  • Masoli M, Fabian D, Holt S, Beasley R, Program Gif A, Global Initiative for Asthma (GINA) Program The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–478. doi:10.1111/j.1398-9995.2004.00526.x.
  • Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M, Pirina P, Carrozzi L, Dallari R, De Togni A, et al. Poor control increases the economic cost of asthma. Int Arch Allergy Immunol. 2006;141(2):189–198. doi:10.1159/000094898.
  • Sullivan S, Rasouliyan L, Russo P, Kamath T, Chipps B, Group TS, TENOR Study Group Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62(2):126–133. doi:10.1111/j.1398-9995.2006.01254.x.
  • Williams SA, Wagner S, Kannan H, Bolge SC. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med. 2009;51(7):780–785. doi:10.1097/JOM.0b013e3181abb019.
  • Cole MB, Nguyen KH. Unmet social needs among low-income adults in the United States: associations with health care access and quality. Health Serv Res. 2020;55(S2):873–882. doi:10.1111/1475-6773.13555.
  • Baicker K, Allen HL, Wright BJ, Finkelstein AN. The effect of Medicaid on medication use among poor adults: evidence from Oregon. Health Aff (Millwood). 2017;36(12):2110–2114. doi:10.1377/hlthaff.2017.0925.
  • Chandra A, Gruber J, McKnight R. The impact of patient cost-sharing on low-income populations: evidence from Massachusetts. J Health Econ. 2014;33:57–66. doi:10.1016/j.jhealeco.2013.10.008.
  • Protection PA. Affordable Care,. Patient protection and affordable care act. Public Law. 2010;111(48):759–762.
  • Dresden SM, Powell ES, Kang R, McHugh M, Cooper AJ, Feinglass J. Increased emergency department use in Illinois after implementation of the Patient Protection and Affordable Care Act. Ann Emerg Med. 2017;69(2):172–180. doi:10.1016/j.annemergmed.2016.06.026.
  • Gaffney A, McCormick D, Bor DH, Goldman A, Woolhandler S, Himmelstein DU. The effects on hospital utilization of the 1966 and 2014 health insurance coverage expansions in the United States. Ann Intern Med. 2019;171(3):172–180. doi:10.7326/M18-2806.
  • Mulcahy AW, Eibner C, Finegold K. Gaining coverage through Medicaid or private insurance increased prescription use and lowered out-of-pocket spending. Health Aff. 2016;35(9):1725–1733. doi:10.1377/hlthaff.2016.0091.
  • Wen H, Borders TF, Druss BG. Number of Medicaid prescriptions grew, drug spending was steady in Medicaid expansion states. Health Aff (Millwood). 2016;35(9):1604–1607. doi:10.1377/hlthaff.2015.1530.
  • Ghosh A, Simon K, Sommers BD. The effect of health insurance on prescription drug use among low-income adults: evidence from recent Medicaid expansions. J Health Econ. 2019;63:64–80. doi:10.1016/j.jhealeco.2018.11.002.
  • Selden TM, Lipton BJ, Decker SL. Medicaid expansion and Marketplace eligibility both increased coverage, with trade-offs in access, affordability. Health Aff (Millwood). 2017;36(12):2069–2077. doi:10.1377/hlthaff.2017.0830.
  • Olfson M, Wall M, Barry CL, Mauro C, Mojtabai R. Impact of Medicaid expansion on coverage and treatment of low-income adults with substance use disorders. Health Aff (Millwood). 2018;37(8):1208–1215. doi:10.1377/hlthaff.2018.0124.
  • Fry CE, Sommers BD. Effect of Medicaid expansion on health insurance coverage and access to care among adults with depression. Psychiatr Serv. 2018;69(11):1146–1152. doi:10.1176/appi.ps.201800181.
  • Han X, Yabroff KR, Ward E, Brawley OW, Jemal A. Comparison of insurance status and diagnosis stage among patients with newly diagnosed cancer before vs after implementation of the Patient Protection and Affordable Care Act. JAMA Oncol. 2018;4(12):1713–1720. doi:10.1001/jamaoncol.2018.3467.
  • Agarwal A, Katz AJ, Chen RC. The Impact of the Affordable Care Act on Disparities in Private and Medicaid Insurance Coverage among Patients Under 65 with Newly Diagnosed Cancer. Int J Radiat Oncol Biol Phys. 2019;105(1):25–30. doi:10.1016/j.ijrobp.2019.05.033.
  • Muurinen J-M. Demand for health: a generalised Grossman model. J Health Econ. 1982;1(1):5–28. doi:10.1016/0167-6296(82)90019-4.
  • Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Social Behav. 1995;36(1):1–10. doi:10.2307/2137284.
  • Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey 2021 [Available from: https://www.meps.ahrq.gov/mepsweb/.
  • Elixhauser A, Steiner C, Whittington C, McCarthy E. Clinical classifications for health policy research: hospital inpatient statistics, 1995. Healthcare cost and utilization project. HCUP. 1998;3:98–0049.
  • Yawn BP. Differential assessment and management of asthma vs chronic obstructive pulmonary disease. Medsc J Med. 2009;11(1):20.
  • Sullivan PW, Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin S-L, Globe G. The relationship between asthma, asthma control and economic outcomes in the United States. J Asthma. 2014;51(7):769–778. doi:10.3109/02770903.2014.906607.
  • Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med. 2019;200(9):1102–1112. doi:10.1164/rccm.201901-0016OC.
  • Multum [Internet]. Denver (CO): Cerner Corporation. Solutions 2021. Available from https://www.cerner.com/solutions/drug-database.
  • HealthCare.gov. Medicaid expansion & what it means for you 2014. [updated 2022; cited 2022 12/25]. Available from: https://www.healthcare.gov/medicaid-chip/medicaid-expansion-and-you/#:∼:text=When%20the%20health%20care%20law,%2C%20family%20status%2C%20or%20health.
  • Yu SMW, Zodet M. Computing Standard Errors for MEPS Estimates 2005. Available from http://www.meps.ahrq.gov/survey_comp/standard_errors.jsp.
  • Statistics NCfH. Table 38. Prescription drug use in the past 30 days, by sex, race and Hispanic origin, and age: united States, selected years 1988–1994 through 2013–2016 2018 [Available from: https://www.cdc.gov/nchs/data/hus/2018/038.pdf.
  • Statistics NCfH. Health, United States, 2018. Hyattsville, MD. 20192019.
  • Medicaid.gov. Medicaid Drug Rebate Program 2018 [Available from: https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html.
  • Carrier E, Cunningham P. Medical cost burdens among nonelderly adults with asthma. Am J Manage Care. 2014;20(11):925–932.
  • Barnett SBL, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011;127(1):145–152. doi:10.1016/j.jaci.2010.10.020.
  • Chua K-P, Sommers BD. Changes in health and medical spending among young adults under health reform. JAMA. 2014;311(23):2437–2439. doi:10.1001/jama.2014.2202.
  • Miller S, Wherry LR. Health and access to care during the first 2 years of the ACA Medicaid expansions. N Engl J Med. 2017;376(10):947–956. doi:10.1056/NEJMsa1612890.
  • Mahendraratnam N, Dusetzina SB, Farley JF. Prescription drug utilization and reimbursement increased following state Medicaid expansion in 2014. J Manag Care Spec Pharm. 2017;23(3):355–363. doi:10.18553/jmcp.2017.23.3.355.
  • Cher BA, Morden NE, Meara E. Medicaid expansion and prescription trends: opioids, addiction therapies, and other drugs. Med Care. 2019;57(3):208–212. doi:10.1097/MLR.0000000000001054.
  • Myerson R, Lu T, Tonnu-Mihara I, Huang ES. Medicaid eligibility expansions may address gaps in access to diabetes medications. Health Aff (Millwood). 2018;37(8):1200–1207. doi:10.1377/hlthaff.2018.0154.
  • Maclean JC, Cook BL, Carson N, Pesko MF. Public insurance and psychotropic prescription medications for mental illness. National Bureau of Economic Research; 2017. Report No.: 0898-2937.
  • Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, Dixon AE, Elward KS, Hartert T, Krishnan JA, et al. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146(6):1217–1270. doi:10.1016/j.jaci.2020.10.003.
  • FitzGerald JM, Tavakoli H, Lynd LD, Al Efraij K, Sadatsafavi M. The impact of inappropriate use of short acting beta agonists in asthma. Respir Med. 2017;131:135–140. doi:10.1016/j.rmed.2017.08.014.
  • Zerhouni YA, Trinh Q-D, Lipsitz S, Goldberg J, Irani J, Bleday R, Haider AH, Melnitchouk N. Effect of Medicaid expansion on colorectal cancer screening rates. Dis Colon Rectum. 2019;62(1):97–103. doi:10.1097/DCR.0000000000001260.
  • Soni A. The effects of public health insurance on health behaviors: evidence from the fifth year of Medicaid expansion. Health Econ. 2020;29(12):1586–1605. doi:10.1002/hec.4155.
  • Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.